New York, New York (PRWEB) July 19, 2013
The Stryker hip recall litigation underway in New Jersey’s Bergen County Superior Court continues to move forward, Bernstein Liebhard LLP reports. According to an Order dated July 17th, the parties have reached an agreement regarding the preservation of possible future claims against Stryker entities not currently named as defendants in the Multicounty Litigation, but that may be asserted as such at a later date. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm continues to hear from alleged victims of the Stryker hip recall for Rejuvenate and ABG II hip stems. We are also representing clients in Stryker hip lawsuits that have been filed in the New Jersey litigation, and look forward to additional progress in the proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have allegedly suffered serious complications that may be associated with the Stryker hip recall for Rejuvenate and ABG II Modular-Neck Hip Stems.
Stryker Hip Lawsuits
According to court records, 161 Stryker hip lawsuit filings are pending the New Jersey litigation. All of the lawsuits allege plaintiffs suffered serious injuries, including metallosis, necrosis, osteolysis and premature device failure, due to the propensity of the Rejuvenate and ABG II stems to fret and corrode at the modular neck junction. Court documents indicate that an additional 159 Stryker hip lawsuits have also been transferred to a multidistrict litigation now underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
According to Stryker, patients fitted with Rejuvenate and ABG II stems may be at risk for adverse local tissue reactions characterized by pain and swelling around the hip joint. However, some asymptomatic patients have reportedly also experienced adverse local tissue reactions. Stryker is now advising all patients with the affected implants to undergo medical screening to ensure their hips are functioning properly, regardless of their symptoms. *
The Stryker hip recall was announced in July 2012, and involved some 20,000 Rejuvenate and ABG II hip stems. According to The Wall Street Journal, Stryker disclosed yesterday that it had taken a $170 million charge to cover expenses incurred as a result of recalled products, including the Rejuvenate and ABG II hip stems.**
Individuals allegedly affected by the Stryker hip recall for Rejuvenate and ABG II hip stems may be entitled to compensation for medical bills, lost wages, and pain and suffering. Further information regarding Stryker hip lawsuits is available at Bernstein Liebhard LLP’s website. To learn more, please call 800-511-5092.
**online.wsj.com/article/BT-CO-20130718-712737.html, Wall Street Journal, July 18, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/stryker-hip-recall/stryker-hip-lawsuit/prweb10946716.htm.
Copyright©2012 Vocus, Inc.
All rights reserved